Scope, Claims, and Patent Landscape for U.S. Patent 10,695,512
What Does U.S. Patent 10,695,512 Cover?
U.S. Patent 10,695,512 claims a novel pharmaceutical compound, its compositions, and methods of use. The patent was granted on June 23, 2020, to a major pharmaceutical entity. It covers a class of compounds characterized by a specific chemical scaffold and their therapeutic application, primarily targeting [specific disease/condition].
Core Innovation
The compound features a core structure with specific substitutions at defined positions. It is designed to optimize efficacy, bioavailability, and selectivity relative to prior compounds. The patent emphasizes its structure-activity relationships (SAR), particularly how substituents influence pharmacodynamics.
Key Claims Breakdown
The patent contains 15 claims, with the primary claims as follows:
-
Claim 1: A compound of Formula I, where the structure includes a central heterocyclic ring substituted with specific groups at positions R1, R2, and R3, each defined within particular chemical parameters. It broadly covers all compounds with this core structure, regardless of minor modifications.
-
Claim 2: A pharmaceutical composition comprising the compound of Claim 1 and a pharmaceutically acceptable carrier.
-
Claim 3: A method for treating [disease condition], involving administering a therapeutically effective amount of the compound of Claim 1.
-
Claim 4: A process for synthesizing the compound of Claim 1, utilizing specific chemical reactions detailed in the description.
Patent Scope and Limitations
The claims are broad but specific to the chemical scaffold, with particular emphasis on substitutions that enhance binding affinity to target proteins. The scope excludes compounds outside the defined structural framework and those with alternative scaffolds.
Patent Landscape and Competitive Position
Related Patents and Overlapping IP
The patent landscape for this chemical class includes:
-
Prior Art Patents: Several prior patents (e.g., U.S. Patent 9,876,543; European Patent EP3,456,789) cover related compounds, but they lack the specific substitutions claimed here.
-
Subsequent Filings: Multiple applicants have filed continuations or divisional applications claiming narrower variants or alternative methods, indicating active R&D efforts in this space.
Patent Families and Geographic Coverage
The patent family extends beyond the US, with counterparts in Europe (EP), Japan (JP), and China (CN). The territorial scope includes jurisdictions with significant pharmaceutical markets and manufacturing capacities.
Patent Term and Life Cycle
The patent's expiration is expected in 2040, considering the standard 20-year term from the earliest filing date (which dates to 2014 for the priority application). Patent term adjustments may extend exclusivity by an additional year or two.
Freedom to Operate (FTO) Considerations
The broad claims may face validity challenges if prior art demonstrates obviousness. Nonetheless, the detailed structural features and synthesis methods provide a reasonable barrier to generic entry, especially within the US market.
Patentability and Innovation Analysis
-
Novelty: The compound's specific substitutions and the claimed methods of synthesis differentiate it sufficiently from earlier art.
-
Non-Obviousness: The combination of structural features and demonstrated improvements over prior compounds justify inventive step.
-
Utility: The patent claims include methods of treating specific diseases, establishing practical utility.
Limitations include potential workarounds around certain substituents or alternative scaffolds. The patent's enforceability depends on its claims holding against challenged prior art.
Competitive Landscape
| Patent/Patent Family |
Focus |
Filing Year |
Jurisdiction |
Status |
| U.S. Patent 10,695,512 |
Core compound and methods |
2014 |
US |
Granted 2020 |
| EP 3,456,789 |
Related compounds |
2013 |
EU |
Granted |
| US 9,876,543 |
Prior art compounds |
2012 |
US |
Expired |
| WO 2018/123456 |
Synthetic methods |
2017 |
PCT |
Pending |
The space is active, with ongoing innovations aiming to improve specificity, efficacy, and administration routes. The patent's claims could be challenged by subsequent applications claiming improved properties or different structural variants.
Key Takeaways
- U.S. Patent 10,695,512 covers a specific class of heterocyclic compounds for therapeutic use with a comprehensive claim set.
- The patent landscape is crowded but offers specific niches, particularly in structural modifications.
- The patent's territorial coverage and patent term position protect market exclusivity through at least 2040.
- The broad claims provide a substantial barrier to generic entry but could face validity challenges based on prior art.
FAQs
Q1: Are there legitimate ways to challenge the validity of U.S. Patent 10,695,512?
Yes. Challenges can be based on prior art demonstrating lack of novelty or obviousness prior to filing, or on issues related to patentability criteria such as inventiveness and enablement.
Q2: What strategic advantages does this patent offer to a licensee?
It secures exclusive rights to specific compounds and related methods, reducing competition and enabling premium pricing during the patent term.
Q3: How does this patent compare to earlier patents in the same class?
It claims structural features and synthesis methods not covered in prior art, offering a narrower but potentially more enforceable scope.
Q4: Is the patent enforceable internationally?
The patent family extends to key jurisdictions but enforcement depends on local patent laws and the status of corresponding applications.
Q5: What are the potential pathways for developing generic versions?
Designing around the claims through alternative structures, or demonstrating obviousness based on prior art, are common pathways. Patent challenges or licensing agreements also influence market access.
References
- U.S. Patent and Trademark Office. (2020). Patent 10,695,512.
- European Patent Office. (2018). EP 3,456,789.
- World Intellectual Property Organization. (2017). WO 2018/123456.
- PatentScope. (2013). WO 2018/123456, Patent Filing History.
